A technology transfer grant is public money with one condition attached: a result has to leave a research institution and move toward a market. That sounds like one programme. It is at least three, and they pay different people. Some pay the lab before any company exists. Some pay a company only if a university works alongside it. Some pay a small firm to take in technology that already exists.
Search the phrase and you get a stack of single-agency pages. Each one is accurate, and none tells you which door is yours. This guide maps the main technology transfer grants in the United States, Germany and the EU, and Singapore by two things: who is allowed to apply, and what the grant leaves behind in IP terms.
We read these terms as builders, not as grant writers. EX EPIC finances, patents and deploys breakthrough science, with a EUR 160M+ capital track record and 24 patent families filed under EX IX. Whatever the grant pays for, the patent is what investors end up pricing.
What a technology transfer grant actually pays for
Three kinds of grant hide behind one phrase
Validation grants go to the institution. The researcher stays employed, the IP stays with the university, and the money buys the evidence a licensee or founder will need. Germany's VIP+ and Singapore's gap funds work this way.
Partnership grants go to a company that works with the institution. The company is the applicant. The university is a required partner with a guaranteed share of the work. The US STTR programme is the textbook case, and its full name, Small Business Technology Transfer, is why it dominates the search results.
Adoption grants go to a firm taking in existing technology. These are small, local and fast. They pay a business to bring in a solution from a lab or university, not to invent one.
Get the category wrong and you waste a cycle. A startup cannot apply for a validation grant. A professor cannot apply for STTR without a company.
United States: STTR is the technology transfer grant
The 40/30 rule
STTR funds a small business and a nonprofit research institution working on one project. At NIH, the small business must perform at least 40 percent of the work and the single partnering research institution at least 30 percent, and only US small business concerns may apply. The same page lists NIH's normal ceilings: up to $314,363 for Phase I and $2,095,748 for Phase II.
That split is the transfer mechanism. The lab keeps doing real work while the company learns to own it. It also answers the question professors ask most: under STTR the principal investigator does not have to leave the university.
How much STTR pays, and how crowded it is
The National Science Foundation states its terms plainly. Each company can receive up to $2 million for R&D, NSF takes no equity, and awardees keep full ownership of their company and IP. Phase I runs up to $305,000 and Phase II up to $1,250,000.
The same solicitation shows how small the STTR lane is. NSF expects roughly 180 SBIR Phase I awards a year and roughly 50 STTR Phase I awards. At Phase II the gap widens: about 80 SBIR against about 10 STTR. If your technology really needs the university partner, STTR is the right door. If it does not, SBIR is the wider one.
Other agencies run their own versions with their own calendars. USDA's current STTR and SBIR Phase II call, for example, offers $600,000 to $650,000 per award, funds about 50 percent of applications, is open only to Phase I winners and closes on 17 November 2026.
The IP agreement you sign before you apply
This is the part most applicants underestimate. STTR projects must include an Allocation of Intellectual Property Rights Agreement between the small business and the research institution. Under the Bayh-Dole Act the awardee can keep title to its inventions, but the federal government receives a nonexclusive, paid-up licence to practise them, and holds march-in rights for defined emergencies.
Defence contracts make the stakes explicit. A DoD STTR offer must include a written agreement that allocates ownership of IP from the award and names which party may obtain US or foreign patents; failing to submit it may render the offer ineligible.
Read that as a negotiation that happens before you write a line of the proposal. If the university keeps the inventions and only promises "good faith" licensing talks later, the grant has funded an asset your company does not own. Our guide to technology transfer licensing covers what a workable licence looks like.
Smaller state adoption grants
At the other end of the scale sit state programmes that use the exact phrase. Arkansas runs a Technology Transfer Assistance Grant that funds up to $3,750 of a $5,000 project to move technology from a university, lab or other provider into an Arkansas enterprise, for projects of no more than 90 days. That will not build a company. It can pay for a first test of a licensed method in a real plant, which is sometimes exactly the evidence a licensor needs.
Germany and the EU: money that goes to the lab first
VIP+: validation before anyone founds anything
Germany's federal research ministry funds the step before a spinout or licence. VIP+ supports validation projects of up to three years with up to EUR 1.5 million, open to any field, for researchers at universities and publicly funded research institutes. The listed outcomes are spinouts, licences, patents and products.
The programme FAQ settles two practical questions. Companies, startups included, are not eligible; the success rate in the pilot phase was around 20 percent; and a funding decision usually takes four to six months after a complete application, with at least four more months before the grant is formally approved. Plan for close to a year between the idea and the money.
EXIST Forschungstransfer: the spinout bridge
When the team is ready to found, EXIST Forschungstransfer takes over. In Phase I the team is still hosted by the institution, and EXIST covers material costs of up to EUR 250,000, explicitly including patent costs. Phase II then funds the new company, with a matching requirement that changes its character. We break that clause down in our guide to equity-free funding for deep tech startups, so we will not repeat it here.
The transfer point to watch is the handover. Inventions made in Phase I belong to the institution. The company needs a licence or assignment before investors will treat them as company assets.
EIC Transition: the EU step up from a funded project
At European level, the EIC Transition is built for results that already came out of EU funding. It offers grants of up to EUR 2.5 million to take a technology from TRL 4 to TRL 5 or 6 and build market readiness, open to SMEs, spinouts, universities and research organisations, with an overall 2026 budget of EUR 100 million.
Smaller calls exist too. The UNITA university alliance, for example, ran a round of advanced tech transfer grants of at most EUR 14,466.66 per project, for up to six projects moving from TRL 4 to TRL 6. Useful seed money for a consortium, not a company budget.
Singapore: gap funds held by the institution
NRF Central Gap Fund
Singapore routes most transfer money through its public research performers. The National Research Foundation's Central Gap Fund supports projects of up to S$2 million, including 30 percent overheads, for up to two years. Eligible applicants are A*STAR institutes, the autonomous universities, public hospitals and similar bodies. Unless the project already received translation funding, the host institution co-funds: equally up to S$500,000 of qualifying costs, and S$250,000 above that. The team must include a business development lead, not only scientists.
University gap funds
Below the national fund sit the universities' own schemes. The NTUitive Gap Fund awards up to S$250,000 over 18 months to projects beyond proof of concept, with NTU's venture building team supporting awardees.
The handover to a startup
Singapore's clearest model of the full transfer is a pathway, not a single grant. The I2S programme chains two institution-held grants capped at S$300,000 each with Enterprise Singapore's Startup SG Tech for the company that results. That last stage requires Singapore incorporation with at least 30 percent local shareholding, and paid-up capital of 10 or 20 percent of the grant. Money follows the IP from the hospital or university to the startup in steps, and each step has a different recipient.
The IP clause decides what the grant is worth
Across all three markets the pattern is the same. Grant money pays for work. The work creates inventions. Who owns those inventions, who may file on them and who may license them is set by the grant terms and the institution's policy, not by the founder's intentions.
Three questions belong in every application review:
- Who holds title when the grant ends? The institution, the company, or the two jointly. Joint ownership without a licensing clause is the slowest outcome of all.
- Who files, and who pays for filing? EXIST and VIP+ both allow patent costs. A grant that funds the filing also funds the asset the next investor will price. Our patent strategy for deep tech startups covers timing the first filing against a long development clock.
- What does the funder keep? In the US that is a government licence and march-in rights. Elsewhere it can be a co-funding obligation or a shareholding condition.
From our side of the table, a grant that ends in a well-drafted patent and a signed licence is worth more than a larger grant that ends in a publication and an open negotiation.
How to pick the right technology transfer grant
Start from where the IP sits today, not from the biggest number.
- IP inside a university, no company yet: institution-side validation money. VIP+ in Germany, Central Gap or a university gap fund in Singapore.
- IP licensed or about to be licensed to a US company, lab still needed: STTR, with the IP allocation agreement negotiated first.
- A team ready to spin out in Germany: EXIST Forschungstransfer, then private money. Our map of university spinout funding shows what comes after.
- A result from an EU-funded project at TRL 4: EIC Transition.
- An existing firm adopting lab technology: look for a state or regional adoption grant first. It is small, but fast.
The grant buys evidence. Someone still has to turn the evidence into a company with operators, customers and protected IP. That is where a builder differs from a transfer office, a difference we cover in venture studio versus technology transfer office.
FAQ
Can a non-US company apply for an STTR grant?
No. Only US small business concerns can apply, in partnership with a university or other nonprofit research institution. A team based abroad would first need an eligible US company to be the applicant.
Can a startup apply for VIP+ funding in Germany?
No. Companies are not eligible. Researchers at universities and publicly funded research institutes apply, and the startup typically comes later through EXIST or a licence.
Does a technology transfer grant take equity?
STTR takes none. The cost is different: the federal government receives a licence to use inventions made with the money. Some programmes in other markets attach co-funding or shareholding conditions, so read each one.
What is the difference between SBIR and STTR?
STTR requires a research institution partner that performs at least 30 percent of the work, plus a written agreement allocating IP rights between the company and the institution. SBIR has no partner requirement and many more awards each year.